title: [Neoplastic obstructive jaundice: palliative treatment with self-expandable metallic prosthesis].
abstract: OBJECTIVE
  Study of the effectiveness and morbidity of palliative treatment of malignant obstructive jaundice with metallic biliary endoprosthesis compared to surgical palliation.
  
  
  METHODS
  Retrospective review.
  
  
  METHODS
  35 patients with non-resectable neoplasms causing jaundice were treated with percutaneous stent (pancreatic carcinoma, n = 11; cholangiocarcinoma, n = 11; gallbladder carcinoma, n = 4; extrahepatic metastases of various malignancies, n = 8).
  
  
  METHODS
  23 patients with malignant jaundice treated with palliative surgery.
  
  
  RESULTS
  Most frequent complications were cholangitis and stent obstruction. The mean hospital stay after the stent placement was 6.8 days, longer in patients with complications (p = 0.035). Recurrence of jaundice was seen in 22.9% of the patients and the rate of readmission was 42.9%. The mean survival was 163.33 days (range 19-522). Reduction in serum bilirubin after BE was significant (215 vs. 82 mmol/l, p < 0.001).
  
  
  CONCLUSIONS
  Comparing to our previous experience with surgical palliative treatment, there was no significant difference neither in morbidity-mortality, nor recurrence or readmission. Patients with pancreatic cancer and cholangiocarcinoma benefit from a shorter hospital stay.
authors.affiliation: Servicio de Cirugía General y Digestiva, Ciudad Sanitaria y Universitaria de Bellvitge, L'Hospitalet de Llobregat, Barcelona.
authors.forename: A
authors.initials: A
authors.lastname: Aldeano
authors.forename: C
authors.initials: C
authors.lastname: Sanz
authors.forename: J
authors.initials: J
authors.lastname: Figueras
authors.forename: J
authors.initials: J
authors.lastname: Domínguez
authors.forename: C
authors.initials: C
authors.lastname: Sancho
authors.forename: L
authors.initials: L
authors.lastname: Fernández Cabrera
authors.forename: A
authors.initials: A
authors.lastname: Rafecas
authors.forename: J
authors.initials: J
authors.lastname: Fabregat
authors.forename: J
authors.initials: J
authors.lastname: Torras
authors.forename: X
authors.initials: X
authors.lastname: Muntaña
mesh_terms: D000368:Aged; D018281:Cholangiocarcinoma / Q000150:complications*; D002779:Cholestasis / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D005500:Follow-Up Studies; D005706:Gallbladder Neoplasms / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications*; D008670:Metals; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000150:complications*; D011183:Postoperative Complications; D011859:Radiography; D012189:Retrospective Studies; D015607:Stents; D013997:Time Factors
chemical_list: D008670:Metals
vernacular_title: Ictericia obstructiva neoplásica. Tratamiento paliativo con prótesis metálica autoexpandible.